This document outlines an exclusive GP-led secondary deal for Project Klein, expected to close in June 2018. It involves a mid-market buyout strategy in Europe/UK, focusing on business and healthcare services. The investment includes four companies, with key value drivers in the UK premium distribution and medical/cosmetics sectors. Glendower Capital manages the transaction, leveraging its expertise in complex deals and long-standing relationships.
doj/DataSet10/EFTA01389539.pdf
{"title":"SOF IV — Project Klein","key_people":["Glendower Team"],"document_date":"June 2018","document_type":"tabular","key_locations":["Europe","UK","Italy"],"document_subtype":"investment summary","key_organizations":["Glendower Capital","Georgetown University Endowment"]}